International Patent: BISPECIFIC ANTI-PD-1 X ANTI-VEGF-A FOR THE TREAMTENT OF METASTATIC NON-SMALL CELL LUNG CANCER

GENEVA, Oct. 5 -- SUMMIT THERAPEUTICS INC. filed a patent application (US2026/020577) for “BISPECIFIC ANTI-PD-1 X ANTI-VEGF-A FOR THE TREAMTENT OF METASTATIC NON-SMALL CELL LUNG CANCER”. With publication no. WO/2026/206973, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61P 35/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....